SG11201604702YA - Biomakers of de novo lipogenesis and methods using the same - Google Patents

Biomakers of de novo lipogenesis and methods using the same

Info

Publication number
SG11201604702YA
SG11201604702YA SG11201604702YA SG11201604702YA SG11201604702YA SG 11201604702Y A SG11201604702Y A SG 11201604702YA SG 11201604702Y A SG11201604702Y A SG 11201604702YA SG 11201604702Y A SG11201604702Y A SG 11201604702YA SG 11201604702Y A SG11201604702Y A SG 11201604702YA
Authority
SG
Singapore
Prior art keywords
biomakers
methods
same
novo lipogenesis
lipogenesis
Prior art date
Application number
SG11201604702YA
Inventor
Steven M Watkins
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of SG11201604702YA publication Critical patent/SG11201604702YA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7057(Intracellular) signaling and trafficking pathways
    • G01N2800/7066Metabolic pathways
    • G01N2800/7085Lipogenesis or lipolysis, e.g. fatty acid metabolism
SG11201604702YA 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same SG11201604702YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361918866P 2013-12-20 2013-12-20
US201461934033P 2014-01-31 2014-01-31
PCT/US2014/071035 WO2015095451A1 (en) 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same

Publications (1)

Publication Number Publication Date
SG11201604702YA true SG11201604702YA (en) 2016-07-28

Family

ID=53403674

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604702YA SG11201604702YA (en) 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same

Country Status (9)

Country Link
US (1) US20160356798A1 (en)
EP (1) EP3082833B1 (en)
JP (1) JP6557235B2 (en)
AU (1) AU2014364539B2 (en)
CA (1) CA2933571A1 (en)
ES (1) ES2708807T3 (en)
MX (1) MX2016008045A (en)
SG (1) SG11201604702YA (en)
WO (1) WO2015095451A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105400732A (en) * 2015-11-19 2016-03-16 南京理工大学 Establishment method for alcoholic fatty liver zebra fish model
US9949915B2 (en) 2016-06-10 2018-04-24 Clarity Cosmetics Inc. Non-comedogenic and non-acnegenic hair and scalp care formulations and method for use
GB201614455D0 (en) * 2016-08-24 2016-10-05 Univ Oxford Innovation Ltd Biomarkers
US11709169B2 (en) * 2017-02-07 2023-07-25 National Jewish Health Lipid abnormalities and association with atopic allergic diseases
JP2020512559A (en) * 2017-03-31 2020-04-23 メタボロン,インコーポレイテッド Comprehensive and quantitative analysis of lipids and tocopherols
US11642300B2 (en) 2019-05-15 2023-05-09 Johnson & Johnson Consumer Inc. Method of selecting skin treatment regimens, ingredients and compositions
US20220142560A1 (en) 2020-11-06 2022-05-12 Johnson & Johnson Consumer Inc. Microbiome and metobolome clusters to evaluate skin health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1438420T3 (en) * 2001-09-24 2010-01-18 Lipomics Technologies Inc Methods for using quantitative lipid metaboma data
JP4682980B2 (en) * 2004-04-23 2011-05-11 味の素株式会社 Nonalcoholic steatohepatitis discrimination method
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
EP2891885A3 (en) * 2007-04-18 2015-10-14 Health Diagnostic Laboratory, Inc. Diabetes-related biomarkers and methods of use thereof
WO2010028336A2 (en) * 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
WO2012040318A2 (en) * 2010-09-23 2012-03-29 University Of Miami Compositions, methods and kits for detecting melanoma and margins of melanoma

Also Published As

Publication number Publication date
JP2017500567A (en) 2017-01-05
US20160356798A1 (en) 2016-12-08
CA2933571A1 (en) 2015-06-25
ES2708807T3 (en) 2019-04-11
AU2014364539A1 (en) 2016-06-16
MX2016008045A (en) 2016-10-12
JP6557235B2 (en) 2019-08-07
AU2014364539B2 (en) 2019-08-01
EP3082833A4 (en) 2017-08-09
EP3082833A1 (en) 2016-10-26
WO2015095451A1 (en) 2015-06-25
EP3082833B1 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
HK1220349A1 (en) Stent monitoring assembly and method of use thereof
GB2522298B (en) Opto-physiological sensor and method of assembly
IL240527A0 (en) Dental-prosthetic assembly and dental-prosthetic system
GB201306633D0 (en) Biaising circuitry and method thereof
HK1209324A1 (en) Nanozymes, methods of making nanozymes, and methods of using nanozymes
SG11201604702YA (en) Biomakers of de novo lipogenesis and methods using the same
GB201301626D0 (en) Composition comprising 15-OHEPA and methods of using the same
HK1224307A1 (en) Protoxin-ii variants and methods of use -ii
EP2985314A4 (en) Contacting component and structure containing said contacting component
HK1231503A1 (en) Gene mutant and application thereof
ZA201600927B (en) Structural assembly and method of assembly thereof
IL245272B (en) Pif-transfected cells and methods of use
IL246270A0 (en) Differential assembly and method
GB201309178D0 (en) Enzyme and uses thereof
SG11201600737TA (en) Instrument changing assembly and methods
GB2584039B (en) Container assembly and method
GB201320359D0 (en) Assembly and method
GB201308285D0 (en) Method and document
GB201311696D0 (en) Assembly and methods
GB201401001D0 (en) Enzyme function probes
GB201308639D0 (en) Biomarkers and uses of thereof
IL242818B (en) Il-1beta-il-1ra chimera and methods of using the same
GB2519994B (en) Assemblies and methods
GB2522839B (en) Method and document
GB2511409B (en) Object production and assessment